HALO stock results show that Halozyme Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. More
Articles
APEI Stock Earnings: American Public Education Beats EPS, Beats Revenue for Q1 2024
APEI stock results show that American Public Education beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. More
AGL Stock Earnings: Agilon Health Beats EPS, Beats Revenue for Q1 2024
AGL stock results show that Agilon Health beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. More
DNMR Stock Earnings: Danimer Scientific Meets EPS, Misses Revenue for Q1 2024
DNMR stock results show that Danimer Scientific met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. More
VTEX Stock Earnings: Vtex Misses Revenue for Q1 2024
VTEX stock results show that Vtex missed on revenue for the first quarter of 2024. More
RIGL Stock Earnings: Rigel Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024
RIGL stock results show that Rigel Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. More
POWI Stock Earnings: Power Integrations Beats EPS, Beats Revenue for Q1 2024
POWI stock results show that Power Integrations beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. More
